Urgency, Incontinence Improve After Anterior Urethroplasty

Share this content:
Urgency, Incontinence Improve After Anterior Urethroplasty
Urgency, Incontinence Improve After Anterior Urethroplasty

FRIDAY, Nov. 18, 2016 (HealthDay News) -- Many males undergoing anterior urethroplasty experience improvement in urgency and urge incontinence, according to a study published in the December issue of The Journal of Urology.

Lindsay A. Hampson, M.D., from the University of California, San Francisco, and colleagues examined urinary urgency and urge incontinence before and after anterior urethroplasty. They retrospectively identified male patients who underwent one-stage anterior urethroplasty. Participants had preoperative and two-month or greater postoperative subjective urinary urgency assessments. Symptom and follow-up data were available in 439 and 305 patients, respectively, on urgency and urge incontinence.

The researchers found that 58 and 31 percent of the men, respectively, reported urgency and urge incontinence preoperatively. This decreased to 40 and 12 percent, respectively, postoperatively (both P < 0.01). Overall, 37 and 74 percent of the men reported improvement in urgency and urge incontinence, respectively. Few men without preoperative symptoms reported worse symptoms (9 and 5 percent, respectively, for urgency and urge incontinence). Men with a higher body mass index were more likely to develop new urgency (odds ratio, 1.09). Improvement in urgency was less likely for men with stricture recurrence (odds ratio, 0.24). Older men were more likely to have new urge incontinence and less likely to notice urge symptom improvement (odds ratios, 1.06 and 0.92, respectively).

"The majority of men experience symptom stability or improvement in urinary urge symptoms following anterior urethroplasty," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »